Randomized clinical trial of transcatheter arterial chemoembolization plus radiofrequency ablation versus transcatheter arterial chemoembolization for hepatocellular carcinoma with intermediate stage (BCLC stage B) hepatocellular carcinoma beyond Milan criteria.

Xin Yin,Bei Tang,Yu-Hong Gan,Yan-Hong Wang,Yi Chen,Ning-lin Ge,Rong-Xin Chen,Lan Zhang,Bo-Heng Zhang,Zhenggang Ren

Randomized clinical trial of transcatheter arterial chemoembolization plus radiofrequency ablation versus transcatheter arterial chemoembolization for hepatocellular carcinoma with intermediate stage (BCLC stage B) hepatocellular carcinoma beyond Milan criteria.

2019

Xin Yin
Bei Tang
Yu-Hong Gan
Yan-Hong Wang
Yi Chen
Ning-lin Ge
Rong-Xin Chen
Lan Zhang
Bo-Heng Zhang
Zhenggang Ren

4077Background: To determine treatment efficacy and safety of transarterial chemoembolization (TACE) combined with radiofrequency ablation (RFA) (hereafter, TACE+RFA) in patients with intermediate ...

Keywords:

Transcatheter arterial chemoembolization
Hepatocellular carcinoma
Radiofrequency ablation
Randomized controlled trial
BCLC Stage B Hepatocellular Carcinoma
Pathology
Radiology
Milan criteria
Medicine
in patient
intermediate stage

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations